Ceyoka (Pvt.) Ltd, the nation’s leading diversified entity, recently announced it has signed a milestone exclusive distributor agreement with Eurofarma, one of the largest pharmaceutical companies in Brazil. 

Under the terms of the exclusive agreement (oncological products), Ceyoka has received the sole legal rights from Eurofarma to import, stock, promote, market and distribute its range of pharmaceuticals in Sri Lanka. 

Ceyoka’s Pharmaceutical Division is recognized as a leader in pharmaceutical distribution in Sri Lanka, importing basic to high-end pharmaceuticals from the USA, Switzerland, China, India, Pakistan, Malaysia, Bangladesh, Malaysia Korea, etc.

Its vast portfolio includes a broad spectrum of products which the company engages in distribution, marketing, sales and business development. Over the last three years, Ceyoka has grown over 100 percent. 

Today, Ceyoka’s Pharmaceutical Division is recognized amongst the top generic, branded generic and innovative pharmaceuticals, distributors in the country and also for bio- similar and oncology products. 

The landmark agreement with Ceyoka, signals the first foray by a Brazil-based multinational pharmaceutical company into the country. Ceyoka retains the exclusive right in Sri Lank to promote and distribute products under the Eurofarma trade mark.

“We are very pleased that Eurofarma Brazil has chosen Ceyoka for its market expansion in bringing their impressive and innovative product portfolio to the Sri Lankan market,” said Ceyoka Health General Manager and Head of Pharmaceuticals Dr. Syed Qamar Ali (MBBS, MD, MBA-Health).

“Our scale of operation, experience and industry know-how provide exceptional distribution opportunities for Eurofarma. The agreement is consistent with our strategy of evolving and expanding. We are confident that with Eurofama and Ceyoka business partnership, both will be able to grow strength to strength in a sustainable manner.” 

With a broadly defined scope that includes hospital therapeutics, Eurofarma operates virtually in all pharmaceutical segments through its business units such as prescription drugs, generics, hospital procurement and oncology. 

Eurofarma’s mission promotes access to health and quality of life with fairly priced treatments in a profitable manner assuring sustainable growth to the company, generating value for its workforce and society. 

Commenting on the agreement Export Department and International Area Executive Director Eurofarma Brazil Wesley Marucci Pontes noted, “This is an important step forward in our strategy to grow our business in key markets and improve global access to our medicines. Creating a strategic partnership with Ceyoka will be a key success factor to offer doctors and patients with high-quality new treatment opportunities in the Sri Lankan healthcare sector.”

The new agreement contributes towards Ceyoka’s commitment provide customers with the highest quality generic pharmaceutical products and services. The agreement also represents an excellent opportunity for reinforcing Ceyoka’s dedication to consistency and excellence.

Ceyoka’s strong marketing team includes highly qualified personnel and its extensive distribution network which guarantees reaching locations islandwide within three to four hours, which creates distinct competitive edge offering best-in-class solutions to our customers.